Researchers have developed a method to predict early on which patients with breast cancer are most likely to stop taking potentially life-saving aromatase inhibitor drugs.
In a pilot study, a telephone-based dietary intervention designed to improve bowel function was shown to be widely acceptable to participants who had had surgery for rectal cancer.
